Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ombretta Repetto

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
International Journal of Molecular Sciences|April 3, 2020
Proteomic Profiles and Biological Processes of Relapsed vs. Non-Relapsed Pediatric Hodgkin LymphomaOmbretta Repetto, Valli De Re, Lara Mussolin, et al.
Biomaterials Advances|August 15, 2025
A patient-derived decellularized extracellular matrix hydrogel as a biomimetic scaffold for advanced 3D colorectal cancer modelingEdoardo D'Angelo, Asia Marangio, Francesca Sensi, et al.
Clinical and Experimental Rheumatology|December 27, 2023
Secretagogue effect of PDE4 inhibitor apremilast on human salivary gland organoids obtained from primary Sjögren's syndrome patientsValeria Manfrè, Salvatore Parisi, Isabella Caligiuri, et al.
Diagnostics (Basel, Switzerland)|June 2, 2021
Proteomic Exploration of Plasma Exosomes and Other Small Extracellular Vesicles in Pediatric Hodgkin Lymphoma: A Potential Source of Biomarkers for Relapse OccurrenceOmbretta Repetto, Federica Lovisa, Caterina Elia, et al.
International Journal of Molecular Sciences|December 16, 2020
Overview of Epstein-Barr-Virus-Associated Gastric Cancer Correlated with Prognostic Classification and Development of Therapeutic OptionsValli De Re, Giulia Brisotto, Ombretta Repetto, et al.
International Journal of Pharmaceutics|January 5, 2025
Tumor microenvironment-mimicking macrophage nanovesicles as a targeted therapy platform for colorectal cancerEdoardo D'Angelo, Riccardo Rampado, Francesca Sensi, et al.
International Journal of Molecular Sciences|September 9, 2022
Quantitative Plasma Proteomics to Identify Candidate Biomarkers of Relapse in Pediatric/Adolescent Hodgkin LymphomaOmbretta Repetto, Laura Caggiari, Mariangela De Zorzi, et al.
Microbial Pathogenesis|August 11, 2025
The function of the HtrA protease in maintaining homeostasis of the human pathogen Helicobacter pyloriUrszula Zarzecka, Ombretta Repetto, Patrycja Ambroziak, et al.
Cancer Letters|November 15, 2025
Nanoformulation of a Pin1 inhibitor potentiates the efficacy of liposomal doxorubicin in second-line therapy for ovarian cancerGloria Saorin, Matteo Mauceri, Isabella Caligiuri, et al.
Experimental Hematology & Oncology|June 18, 2024
Reconstructed colorectal cancer model to dissect the anti-tumor effect of mesenchymal stromal cells derived extracellular vesiclesEdoardo D'Angelo, Sarah Tassinari, Andrea Biccari, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
International Journal of Molecular Sciences|April 3, 2020
Proteomic Profiles and Biological Processes of Relapsed vs. Non-Relapsed Pediatric Hodgkin LymphomaOmbretta Repetto, Valli De Re, Lara Mussolin, et al.
Biomaterials Advances|August 15, 2025
A patient-derived decellularized extracellular matrix hydrogel as a biomimetic scaffold for advanced 3D colorectal cancer modelingEdoardo D'Angelo, Asia Marangio, Francesca Sensi, et al.
Clinical and Experimental Rheumatology|December 27, 2023
Secretagogue effect of PDE4 inhibitor apremilast on human salivary gland organoids obtained from primary Sjögren's syndrome patientsValeria Manfrè, Salvatore Parisi, Isabella Caligiuri, et al.
Diagnostics (Basel, Switzerland)|June 2, 2021
Proteomic Exploration of Plasma Exosomes and Other Small Extracellular Vesicles in Pediatric Hodgkin Lymphoma: A Potential Source of Biomarkers for Relapse OccurrenceOmbretta Repetto, Federica Lovisa, Caterina Elia, et al.
International Journal of Molecular Sciences|December 16, 2020
Overview of Epstein-Barr-Virus-Associated Gastric Cancer Correlated with Prognostic Classification and Development of Therapeutic OptionsValli De Re, Giulia Brisotto, Ombretta Repetto, et al.
International Journal of Pharmaceutics|January 5, 2025
Tumor microenvironment-mimicking macrophage nanovesicles as a targeted therapy platform for colorectal cancerEdoardo D'Angelo, Riccardo Rampado, Francesca Sensi, et al.
International Journal of Molecular Sciences|September 9, 2022
Quantitative Plasma Proteomics to Identify Candidate Biomarkers of Relapse in Pediatric/Adolescent Hodgkin LymphomaOmbretta Repetto, Laura Caggiari, Mariangela De Zorzi, et al.
Microbial Pathogenesis|August 11, 2025
The function of the HtrA protease in maintaining homeostasis of the human pathogen Helicobacter pyloriUrszula Zarzecka, Ombretta Repetto, Patrycja Ambroziak, et al.
Cancer Letters|November 15, 2025
Nanoformulation of a Pin1 inhibitor potentiates the efficacy of liposomal doxorubicin in second-line therapy for ovarian cancerGloria Saorin, Matteo Mauceri, Isabella Caligiuri, et al.
Experimental Hematology & Oncology|June 18, 2024
Reconstructed colorectal cancer model to dissect the anti-tumor effect of mesenchymal stromal cells derived extracellular vesiclesEdoardo D'Angelo, Sarah Tassinari, Andrea Biccari, et al.
Pageof 4